Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS)
CNY 16.47
(-10.0%)
CNY 16.47
(-10.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.34 Billion CNY | 35.28% |
| 2022 | 2.47 Billion CNY | 9.79% |
| 2021 | 2.25 Billion CNY | 8.15% |
| 2020 | 2.08 Billion CNY | 88.09% |
| 2019 | 1.1 Billion CNY | 1.17% |
| 2018 | 1.09 Billion CNY | -6.17% |
| 2017 | 1.16 Billion CNY | 13.61% |
| 2016 | 1.02 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.39 Billion CNY | 1.43% |
| 2024 Q3 | 3.51 Billion CNY | 5.7% |
| 2024 Q2 | 3.32 Billion CNY | -1.89% |
| 2023 Q3 | 3.38 Billion CNY | 27.71% |
| 2023 Q2 | 2.64 Billion CNY | 5.51% |
| 2023 Q1 | 2.51 Billion CNY | 1.58% |
| 2023 FY | 3.34 Billion CNY | 35.28% |
| 2023 Q4 | 3.34 Billion CNY | -1.16% |
| 2022 Q4 | 2.47 Billion CNY | 6.69% |
| 2022 Q3 | 2.31 Billion CNY | 2.65% |
| 2022 Q2 | 2.25 Billion CNY | -0.67% |
| 2022 FY | 2.47 Billion CNY | 9.79% |
| 2022 Q1 | 2.27 Billion CNY | 0.92% |
| 2021 Q4 | 2.25 Billion CNY | 1.24% |
| 2021 Q3 | 2.22 Billion CNY | 1.01% |
| 2021 Q2 | 2.2 Billion CNY | 2.9% |
| 2021 FY | 2.25 Billion CNY | 8.15% |
| 2021 Q1 | 2.13 Billion CNY | 2.77% |
| 2020 FY | 2.08 Billion CNY | 88.09% |
| 2020 Q4 | 2.08 Billion CNY | 69.99% |
| 2020 Q3 | 1.22 Billion CNY | 1.39% |
| 2020 Q2 | 1.2 Billion CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q2 | 1.11 Billion CNY | 0.0% |
| 2019 FY | 1.1 Billion CNY | 1.17% |
| 2019 Q4 | 1.1 Billion CNY | 0.0% |
| 2018 FY | 1.09 Billion CNY | -6.17% |
| 2017 FY | 1.16 Billion CNY | 13.61% |
| 2016 FY | 1.02 Billion CNY | 0.0% |